# Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.

> **NCT01729221** · — · UNKNOWN · sponsor: **Cairo University** · enrollment: 280 (estimated)

## Conditions studied

- Hepatocellular Carcinoma in Hepatitis C Virus Infected Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01729221
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-12
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2012-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01729221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01729221, "Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01729221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*